CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	At-The Market Offering	Common Stock	Common Stock Restricted Stock Units	Common Stock At-The Market Offering	Additional Paid-in Capital	Additional Paid-in Capital At-The Market Offering	Accumulated Deficit
Balance at Dec. 31, 2021	$ 915,194		$ 2			$ 2,063,974		$ (1,148,782)
Balance (in shares) at Dec. 31, 2021			1,713,662
Stock-based compensation	11,957					11,957
Vesting of restricted stock awards/units (in shares)				9,404
Restricted stock units in accordance with purchase agreement			4,459
Net Income (Loss)	(451,910)							(451,910)
Balance at Dec. 31, 2022	475,241		$ 2			2,075,931		(1,600,692)
Balance (in shares) at Dec. 31, 2022			1,727,525
Issuance of common stock, net of offering costs		$ 2,399					$ 2,399
Issuance of common stock, net of offering costs (in shares)					43,483
Stock-based compensation	$ 10,051					10,051
Exercise of stock options (in shares)	0
Vesting of restricted stock awards/units (in shares)				20,278
Net Income (Loss)	$ (365,540)							(365,540)
Balance at Dec. 31, 2023	$ 122,151		$ 2			$ 2,088,381		$ (1,966,232)
Balance (in shares) at Dec. 31, 2023			1,791,286